AMY KONG: Open Payments
NPI 1104365766 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 5 payments from 4 companies in 2025. Trend: 2023 $817 · 2024 $782 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Abbott Laboratories | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
Products named: UZEDY, ALINITY, DUPIXENT.
Industry payments across CA — which companies pay providers there.
